Hospital Virgen del Camino Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2006
NCT00492076
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Alternative names

HOSPITAL VIRGEN DEL CAMINO - PAMPLONA

Active Ingredients

Drugs in Phase 4 Trials (1)

house dust mite allergen (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 4)

Rhinitis (Phase 3)

Rhinitis, Allergic (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 1